{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:37:22Z","timestamp":1793839042100,"version":"4.6.1"},"reference-count":32,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100006396","name":"Qazvin University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.QUMS.REC.1396.117"],"award-info":[{"award-number":["IR.QUMS.REC.1396.117"]}],"id":[{"id":"10.13039\/501100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>Rheumatoid arthritis (RA) is a systemic inflammatory disease. In recent years, new drugs with novel targets have been developed to increase the efficacy of drugs in the treatment of RA. Curcumin has shown potent anti\u2010inflammatory effects and is considered an anti\u2010tumor necrosis factor. The present study was conducted to determine the effect of curcumin nanomicelle on the clinical symptoms of patients with RA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This randomized, double\u2010blind, controlled trial selected 65 eligible RA patients and randomly divided them into a curcumin nanomicelle group (n\u00a0=\u00a030) and a placebo group (n\u00a0=\u00a035). Curcumin nanomicelle (40\u00a0mg) and placebo capsules were administrated to the RA patients 3 times a day for 12\u00a0weeks. The Disease Activity Score of 28 joints (DAS\u201028) and erythrocyte sedimentation rate (ESR) were measured at baseline and after 12\u00a0weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The DAS\u201028, tender joint count (TJC) and swollen joint count (SJC) at baseline and the end of the study were not significant between the curcumin nanomicelle and placebo groups. After the intervention, the within\u2010group DAS\u201028, TJC and SJC in the curcumin nanomicelle and placebo groups reduced significantly compared to the baseline. The difference in changes between the two groups was not significant. Nonetheless, this change was greater in the case group than in the placebo group. No significant changes were observed in terms of ESR between the two groups of RA patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Adding curcumin nanomicelle to the RA patients\u2019 medication led to some positive changes in the DAS\u201028, IJC and SJC, although not significantly.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1756-185x.13688","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T08:17:50Z","timestamp":1567585070000},"page":"1857-1862","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double\u2010blind, controlled trial"],"prefix":"10.1111","volume":"22","author":[{"given":"Maryam","family":"Javadi","sequence":"first","affiliation":[{"name":"Children Growth Research Center Qazvin University of Medical Sciences Qazvin Iran"},{"name":"Department of Nutrition, School of Health Qazvin University of Medical Sciences Qazvin Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Khadem Haghighian","sequence":"additional","affiliation":[{"name":"Department of Nutrition, School of Health Qazvin University of Medical Sciences Qazvin Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Goodarzy","sequence":"additional","affiliation":[{"name":"Department of Nutrition, School of Health Qazvin University of Medical Sciences Qazvin Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Abbasi","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Research Center Qazvin University of Medical Sciences Qazvin Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3701-0758","authenticated-orcid":false,"given":"Marjan","family":"Nassiri\u2010Asl","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Research Center Qazvin University of Medical Sciences Qazvin Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"issue":"1","key":"e_1_2_8_2_1","first-page":"010409","article-title":"Prevalence of rheumatoid arthritis in low\u2013 and middle\u2013income countries: A systematic review and analysis","volume":"5","author":"Rudan I","year":"2015","journal-title":"J Glob Health"},{"issue":"2","key":"e_1_2_8_3_1","first-page":"144","article-title":"Biomarkers in Rheumatoid Arthritis, what is new?","volume":"9","author":"Gavril\u0103 BI","year":"2016","journal-title":"J Med Life"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hcl.2010.09.002"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-018-0016-9"},{"key":"e_1_2_8_6_1","first-page":"1","article-title":"New strategies for patenting biological medicines used in rheumatoid arthritis treatment","volume":"3","author":"Oliveira RA","year":"2018","journal-title":"Expert Opin Ther Pat"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4261-5"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcme.2016.05.005"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1021\/np050327j"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13069"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.03.025"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13621"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2013.01.003"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145539"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2011.06.006"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12156"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-016-1376-9"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/0960327109359020"},{"issue":"5","key":"e_1_2_8_19_1","first-page":"567","article-title":"The effect of nano\u2010curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial","volume":"6","author":"Rahimi HR","year":"2016","journal-title":"Avicenna J Phytomed"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.11.053"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2010.03.001"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2009.00711.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.07.017"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1358\/mf.2009.31.2.1357705"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.2165\/00126839-200809040-00004"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.3109\/07357907.2010.550592"},{"issue":"3","key":"e_1_2_8_27_1","first-page":"365","article-title":"Curcumin induces apoptosis and inhibits prostaglandin E(2) production in synovial fibroblasts of patients with rheumatoid arthritis","volume":"20","author":"Park C","year":"2007","journal-title":"Int J Mol Med"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2016.5674"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.4639"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1089\/jmf.2017.3930"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.620"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.8b06236"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2019.01.012"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185X.13688","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1756-185X.13688","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185X.13688","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T08:39:39Z","timestamp":1694248779000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1756-185X.13688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1111\/1756-185X.13688"],"URL":"https:\/\/doi.org\/10.1111\/1756-185x.13688","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]},"assertion":[{"value":"2018-09-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}